Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience.
Tropé C, Hogberg T, Kaern J, Bertelsen K, Bjorkholm E, Boman K, Himmelmann A, Horvath G, Jacobsen A, Kuoppola T, Vartianen J, Lund B, Onsrud M, Puistola U, Salmi T, Scheistroen M, Sandvei R, Simonsen E, Sorbe B, Tholander B, Westberg R.
Tropé C, et al. Among authors: himmelmann a.
Ann Oncol. 1998 Dec;9(12):1301-7. doi: 10.1023/a:1008400324892.
Ann Oncol. 1998.
PMID: 9932160
Free article.
Clinical Trial.